Cheshire, UK--(Marketwire - July 25, 2008) - London, UK; Brentwood, TN, US: 25 July 2008 - In accordance with
Prospectus Rule 5.2, Protherics PLC ("Protherics" or the "Company"),
the international biopharmaceutical company focused on critical care
and cancer, sets out below a list of the information that has been
published or made available to the public during the period
beginning 20 July 2007 up to and including 24 July 2008.
